Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial.
Andra Rodica BalanescuGustavo CiteraVirginia Pascual-RamosDeepak L BhattCarol A ConnellDavid GoldAll-Shine ChenGosford SawyerrAndrea B ShapiroJanet E PopeHendrik Schulze-KoopsPublished in: Annals of the rheumatic diseases (2022)
NCT02092467.